642 In a multicenter, randomized, double-blind, placebo-controlled phase-3 clinical trial conducted in China, acetyllevocarnitine hydrochloride treatment for 24 weeks significantly improved symptoms and somatosensory symptoms in patients with DPN, with a treatment effect of 65% higher than placebo
Special imaging techniques can provide a detailed view of these changes, which can then be confirmed through biopsy and histopathological analysis
Shiu HY, Chong HC, Leung YC, Wong MK, Che CM
Tirzepatide should only be injected into the three approved areas: the abdomen, thigh, or back of the upper arm
That's where salmon DNA comes in
A typical loading approach might use 0.75mg to 1mg daily for the first 3 to 5 days, then reduce to 0.5mg for the remainder of the protocol